Pamela Munster, MD

Professor

Department of Medicine

[email protected]

Primary Thematic Area:

Cancer Biology & Cell Signaling

Secondary Thematic Area:

None

Publications:

Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Zandberg DP, Allred JB, Rosenberg AJ, Kaczmar JM, Swiecicki P, Julian RA, Poklepovic AS, Bauman JR, Phan MD, Saba NF, Rivera E, Rowland K, Davar D, Cordes J, Ho AL, Zhang M, Berg SA, Munster PN, Schwartz GK

Characterizing safety, toxicity, and breast cancer risk reduction using a long-term fulvestrant eluting implant.

Scientific reports

Thomas S, Roche E, Desai P, Pawlowska N, Bauer D, Gingrich D, Hsu E, Deitchman AN, Aweeka F, Munster PN

Low dose DNA methyltransferase inhibitors potentiate PARP inhibitors in homologous recombination repair deficient tumors.

Breast cancer research : BCR

Pacaud R, Thomas S, Chaudhuri S, Lazar A, Timmerman LA, Munster PN

A first-in-human phase 1/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignancies.

European journal of cancer (Oxford, England : 1990)

Ribrag V, Iglesias L, De Braud F, Ma B, Yokota T, Zander T, Spreafico A, Subbiah V, Illert AL, Tan D, Santoro A, Munster PN, Suehiro Y, Wang Y, Ji DM, Chen S, Beltz K, Suenaga N, Ramkumar T, Luo F, Lai C, Wainberg ZA

Estrogens and breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology

Kim J, Munster PN